Alterações em células dendríticas derivadas de monócitos e em monócitos de pacientes com câncer de mama

Breast cancer is an important cause of morbidity and mortality in Brazil and worldwide. New therapeutic strategies have been proposed and one of them is the use of cell therapy with dendritic cells (DCs), however, the literature regarding the real benefit of this approach shows great variability and